Alzheimer's disease-related changes in diseases characterized by elevation of intracranial or intraocular pressure

Clinical Neurology and Neurosurgery

Volumn 110, Issue 2, 2008, Pages 101-109

  Wostyn, Peter ^a   Audenaert, Kurt ^b   De Deyn, Peter Paul ^c,d  

^a PC Sint Amandus ^*  (Belgium)

^b GHENT UNIVERSITY HOSPITAL   (Belgium)

^c MIDDELHEIM HOSPITAL   (Belgium)

^d UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

Alzheimer's disease; Glaucoma; Intracranial pressure; Intraocular pressure; Mechanical load; Normal pressure hydrocephalus; Traumatic brain injury

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; CASPASE; NEUROTOXIN; TAU PROTEIN;

ALZHEIMER DISEASE; APOPTOSIS; BRAIN DISEASE; BRAIN TISSUE; CENTRAL NERVOUS SYSTEM; CEREBROSPINAL FLUID; CEREBROSPINAL FLUID FLOW; DISEASE ASSOCIATION; DISEASE COURSE; ENZYME ACTIVATION; GLAUCOMA; HUMAN; INTRACRANIAL PRESSURE; INTRAOCULAR PRESSURE; MECHANICAL STRESS; NEUROPATHOLOGY; NORMOTENSIVE HYDROCEPHALUS; PATHOGENESIS; RETINA GANGLION CELL; REVIEW; RISK FACTOR; SHEAR STRESS; TRAUMATIC BRAIN INJURY;

ALZHEIMER DISEASE; BRAIN INJURIES; GLAUCOMA; HUMANS; HYDROCEPHALUS, NORMAL PRESSURE;

EID: 38348998858     PISSN: 03038467     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clineuro.2007.10.011     Document Type: Review

References (92)

1. Bullock R., and Hammond G. Realistic expectations: the management of severe Alzheimer disease. Alzheimer Dis Assoc Disord 17 Suppl. 3 (2003) S80-S85
2. Evans D.A., Funkenstein H.H., Albert M.S., Scherr P.A., Cook N.R., Chown M.J., et al. Prevalence of Alzheimer's disease in a community population of older persons. Higher than previously reported. JAMA 262 (1989) 2551-2556
3. Selkoe D.J. Alzheimer's disease: genes, proteins, and therapy. Physiol Rev 81 (2001) 741-766
4. Gorelick P.B. Risk factors for vascular dementia and Alzheimer disease. Stroke 35 11 Suppl. 1 (2004) 2620-2622
5. Rocchi A., Pellegrini S., Siciliano G., and Murri L. Causative and susceptibility genes for Alzheimer's disease: a review. Brain Res Bull 61 (2003) 1-24
6. Kahlon B., Sundbarg G., and Rehncrona S. Comparison between the lumbar infusion and CSF tap tests to predict outcome after shunt surgery in suspected normal pressure hydrocephalus. J Neurol Neurosurg Psychiatry 73 (2002) 721-726
7. Kizu O., Yamada K., and Nishimura T. Proton chemical shift imaging in normal pressure hydrocephalus. AJNR Am J Neuroradiol 22 (2001) 1659-1664
8. Silverberg G.D., Mayo M., Saul T., Rubenstein E., and McGuire D. Alzheimer's disease, normal-pressure hydrocephalus, and senescent changes in CSF circulatory physiology: a hypothesis. Lancet Neurol 2 (2003) 506-511
9. Adams R.D., Fisher C.M., Hakim S., Ojemann R.G., and Sweet W.H. Symptomatic occult hydrocephalus with "normal" cerebrospinal-fluid pressure. A treatable syndrome. N Engl J Med 273 (1965) 117-126
10. Bret P., Guyotat J., and Chazal J. Is normal pressure hydrocephalus a valid concept in 2002? A reappraisal in five questions and proposal for a new designation of the syndrome as "chronic hydrocephalus". J Neurol Neurosurg Psychiatry 73 (2002) 9-12
11. Silverberg G.D. Normal pressure hydrocephalus (NPH): ischaemia, CSF stagnation or both. Brain 127 (2004) 947-948
12. Levine D.N. The pathogenesis of normal pressure hydrocephalus: a theoretical analysis. Bull Math Biol 61 (1999) 875-916
13. Triyoso D.H., and Good T.A. Pulsatile shear stress leads to DNA fragmentation in human SH-SY5Y neuroblastoma cell line. J Physiol 515 (1999) 355-365
14. Engelborghs K., Verlooy J., Van Deuren B., Van Reempts J., and Borgers M. Intracranial pressure in a modified experimental model of closed head injury. Acta Neurochir Suppl (Wien) 70 (1997) 123-125
15. Engelborghs K., Verlooy J., Van Reempts J., Van Deuren B., Van de Ven M., and Borgers M. Temporal changes in intracranial pressure in a modified experimental model of closed head injury. J Neurosurg 89 (1998) 796-806
16. Fujiwara S., Yanagida Y., and Mizoi Y. Impact-induced intracranial pressure caused by an accelerated motion of the head or by skull deformation; an experimental study using physical models of the head and neck, and ones of the skull. Forensic Sci Int 43 (1989) 159-169
17. Ueno K., Melvin J.W., Li L., and Lighthall J.W. Development of tissue level brain injury criteria by finite element analysis. J Neurotrauma 12 (1995) 695-706
18. Zhang L., Yang K.H., and King A.I. Comparison of brain responses between frontal and lateral impacts by finite element modeling. J Neurotrauma 18 (2001) 21-30
19. Morrison III B., Cater H.L., Benham C.D., and Sundstrom L.E. An in vitro model of traumatic brain injury utilising two-dimensional stretch of organotypic hippocampal slice cultures. J Neurosci Methods 150 (2006) 192-201
20. Flammer J., Orgul S., Costa V.P., Orzalesi N., Krieglstein G.K., Serra L.M., et al. The impact of ocular blood flow in glaucoma. Prog Retin Eye Res 21 (2002) 359-393
21. Engel D.C., Slemmer J.E., Vlug A.S., Maas A.I., and Weber J.T. Combined effects of mechanical and ischemic injury to cortical cells: secondary ischemia increases damage and decreases effects of neuroprotective agents. Neuropharmacology 49 (2005) 985-995
22. Edwards M.E., Wang S.S., and Good T.A. Role of viscoelastic properties of differentiated SH-SY5Y human neuroblastoma cells in cyclic shear stress injury. Biotechnol Prog 17 (2001) 760-767
23. LaPlaca M.C., and Thibault L.E. An in vitro traumatic injury model to examine the response of neurons to a hydrodynamically-induced deformation. Ann Biomed Eng 25 (1997) 665-677
24. LaPlaca M.C., Lee V.M., and Thibault L.E. An in vitro model of traumatic neuronal injury: loading rate-dependent changes in acute cytosolic calcium and lactate dehydrogenase release. J Neurotrauma 14 (1997) 355-368
25. Geddes D.M., and Cargill II R.S. An in vitro model of neural trauma: device characterization and calcium response to mechanical stretch. J Biomech Eng 123 (2001) 247-255
26. Geddes D.M., Cargill II R.S., and LaPlaca M.C. Mechanical stretch to neurons results in a strain rate and magnitude-dependent increase in plasma membrane permeability. J Neurotrauma 20 (2003) 1039-1049
27. Geddes D.M., LaPlaca M.C., and Cargill II R.S. Susceptibility of hippocampal neurons to mechanically induced injury. Exp Neurol 184 (2003) 420-427
28. Plassman B.L., Havlik R.J., Steffens D.C., Helms M.J., Newman T.N., Drosdick D., et al. Documented head injury in early adulthood and risk of Alzheimer's disease and other dementias. Neurology 55 (2000) 1158-1166
29. Fleminger S., Oliver D.L., Lovestone S., Rabe-Hesketh S., and Giora A. Head injury as a risk factor for Alzheimer's disease: the evidence 10 years on; a partial replication. J Neurol Neurosurg Psychiatry 74 (2003) 857-862
30. Jellinger K.A. Head injury and dementia. Curr Opin Neurol 17 (2004) 719-723
31. Horsburgh K., McCarron M.O., White F., and Nicoll J.A. The role of apolipoprotein E in Alzheimer's disease, acute brain injury and cerebrovascular disease: evidence of common mechanisms and utility of animal models. Neurobiol Aging 21 (2000) 245-255
32. Chamelian L., Reis M., and Feinstein A. Six-month recovery from mild to moderate traumatic brain injury: the role of APOE-epsilon 4 allele. Brain 127 (2004) 2621-2628
33. Graham D.I., Gentleman S.M., Lynch A., and Roberts G.W. Distribution of beta-amyloid protein in the brain following severe head injury. Neuropathol Appl Neurobiol 21 (1995) 27-34
34. Roberts G.W., Gentleman S.M., Lynch A., Murray L., Landon M., and Graham D.I. Beta amyloid protein deposition in the brain after severe head injury: implications for the pathogenesis of Alzheimer's disease. J Neurol Neurosurg Psychiatry 57 (1994) 419-425
35. Roberts G.W., Gentleman S.M., Lynch A., and Graham D.I. Beta A4 amyloid protein deposition in brain after head trauma. Lancet 338 (1991) 1422-1423
36. Smith C., Graham D.I., Murray L.S., and Nicoll J.A. Tau immunohistochemistry in acute brain injury. Neuropathol Appl Neurobiol 29 (2003) 496-502
37. Roberts G.W., Allsop D., and Bruton C. The occult aftermath of boxing. J Neurol Neurosurg Psychiatry 53 (1990) 373-378
38. Uryu K., Laurer H., McIntosh T., Pratico D., Martinez D., Leight S., et al. Repetitive mild brain trauma accelerates Abeta deposition, lipid peroxidation, and cognitive impairment in a transgenic mouse model of Alzheimer amyloidosis. J Neurosci 22 (2002) 446-454
39. Yoshiyama Y., Uryu K., Higuchi M., Longhi L., Hoover R., Fujimoto S., et al. Enhanced neurofibrillary tangle formation, cerebral atrophy, and cognitive deficits induced by repetitive mild brain injury in a transgenic tauopathy mouse model. J Neurotrauma 22 (2005) 1134-1141
40. Olsson A., Csajbok L., Ost M., Hoglund K., Nylen K., Rosengren L., et al. Marked increase of beta-amyloid(1-42) and amyloid precursor protein in ventricular cerebrospinal fluid after severe traumatic brain injury. J Neurol 251 (2004) 870-876
41. Franz G., Beer R., Kampfl A., Engelhardt K., Schmutzhard E., Ulmer H., et al. Amyloid beta 1-42 and tau in cerebrospinal fluid after severe traumatic brain injury. Neurology 60 (2003) 1457-1461
42. Chen X.H., Siman R., Iwata A., Meaney D.F., Trojanowski J.Q., and Smith D.H. Long-term accumulation of amyloid-beta, beta-secretase, presenilin-1, and caspase-3 in damaged axons following brain trauma. Am J Pathol 165 (2004) 357-371
43. Gervais F.G., Xu D., Robertson G.S., Vaillancourt J.P., Zhu Y., Huang J., et al. Involvement of caspases in proteolytic cleavage of Alzheimer's amyloid-beta precursor protein and amyloidogenic A beta peptide formation. Cell 97 (1999) 395-406
44. Stadelmann C., Deckwerth T.L., Srinivasan A., Bancher C., Bruck W., Jellinger K., et al. Activation of caspase-3 in single neurons and autophagic granules of granulovacuolar degeneration in Alzheimer's disease. Evidence for apoptotic cell death. Am J Pathol 155 (1999) 1459-1466
45. Rohn T.T., Head E., Nesse W.H., Cotman C.W., and Cribbs D.H. Activation of caspase-8 in the Alzheimer's disease brain. Neurobiol Dis 8 (2001) 1006-1016
46. Rohn T.T., Head E., Su J.H., Anderson A.J., Bahr B.A., Cotman C.W., et al. Correlation between caspase activation and neurofibrillary tangle formation in Alzheimer's disease. Am J Pathol 158 (2001) 189-198
47. Su J.H., Zhao M., Anderson A.J., Srinivasan A., and Cotman C.W. Activated caspase-3 expression in Alzheimer's and aged control brain: correlation with Alzheimer pathology. Brain Res 898 (2001) 350-357
48. Rohn T.T., Rissman R.A., Davis M.C., Kim Y.E., Cotman C.W., and Head E. Caspase-9 activation and caspase cleavage of tau in the Alzheimer's disease brain. Neurobiol Dis 11 (2002) 341-354
49. Gastard M.C., Troncoso J.C., and Koliatsos V.E. Caspase activation in the limbic cortex of subjects with early Alzheimer's disease. Ann Neurol 54 (2003) 393-398
50. Yakovlev A.G., and Faden A.I. Caspase-dependent apoptotic pathways in CNS injury. Mol Neurobiol 24 (2001) 131-144
51. Knoblach S.M., Nikolaeva M., Huang X., Fan L., Krajewski S., Reed J.C., et al. Multiple caspases are activated after traumatic brain injury: evidence for involvement in functional outcome. J Neurotrauma 19 (2002) 1155-1170
52. Harter L., Keel M., Hentze H., Leist M., and Ertel W. Caspase-3 activity is present in cerebrospinal fluid from patients with traumatic brain injury. J Neuroimmunol 121 (2001) 76-78
53. Stone J.R., Okonkwo D.O., Singleton R.H., Mutlu L.K., Helm G.A., and Povlishock J.T. Caspase-3-mediated cleavage of amyloid precursor protein and formation of amyloid Beta peptide in traumatic axonal injury. J Neurotrauma 19 (2002) 601-614
54. Buki A., Okonkwo D.O., Wang K.K., and Povlishock J.T. Cytochrome c release and caspase activation in traumatic axonal injury. J Neurosci 20 (2000) 2825-2834
55. Sullivan P.G., Keller J.N., Bussen W.L., and Scheff S.W. Cytochrome c release and caspase activation after traumatic brain injury. Brain Res 949 (2002) 88-96
56. McKinnon S.J. Glaucoma: ocular Alzheimer's disease?. Front Biosci 8 (2003) s1140-s1156
57. McKinnon S.J., Lehman D.M., Kerrigan-Baumrind L.A., Merges C.A., Pease M.E., Kerrigan D.F., et al. Caspase activation and amyloid precursor protein cleavage in rat ocular hypertension. Invest Ophthalmol Vis Sci 43 (2002) 1077-1087
58. Barnes N.Y., Li L., Yoshikawa K., Schwartz L.M., Oppenheim R.W., and Milligan C.E. Increased production of amyloid precursor protein provides a substrate for caspase-3 in dying motoneurons. J Neurosci 18 (1998) 5869-5880
59. LeBlanc A., Liu H., Goodyer C., Bergeron C., and Hammond J. Caspase-6 role in apoptosis of human neurons, amyloidogenesis, and Alzheimer's disease. J Biol Chem 274 (1999) 23426-23436
60. Pellegrini L., Passer B.J., Tabaton M., Ganjei J.K., and D'Adamio L. Alternative, non-secretase processing of Alzheimer's beta-amyloid precursor protein during apoptosis by caspase-6 and -8. J Biol Chem 274 (1999) 21011-21016
61. Guenette S.Y., Chen J., Jondro P.D., and Tanzi R.E. Association of a novel human FE65-like protein with the cytoplasmic domain of the beta-amyloid precursor protein. Proc Natl Acad Sci USA 93 (1996) 10832-10837
62. Borg J.P., Ooi J., Levy E., and Margolis B. The phosphotyrosine interaction domains of X11 and FE65 bind to distinct sites on the YENPTY motif of amyloid precursor protein. Mol Cell Biol 16 (1996) 6229-6241
63. Delatour B., Mercken L., El Hachimi K.H., Colle M.A., Pradier L., and Duyckaerts C. FE65 in Alzheimer's disease: neuronal distribution and association with neurofibrillary tangles. Am J Pathol 158 (2001) 1585-1591
64. Borg J.P., Yang Y., De Taddeo-Borg M., Margolis B., and Turner R.S. The X11alpha protein slows cellular amyloid precursor protein processing and reduces Abeta40 and Abeta42 secretion. J Biol Chem 273 (1998) 14761-14766
65. Rissman R.A., Poon W.W., Blurton-Jones M., Oddo S., Torp R., Vitek M.P., et al. Caspase-cleavage of tau is an early event in Alzheimer disease tangle pathology. J Clin Invest 114 (2004) 121-130
66. Gamblin T.C., Chen F., Zambrano A., Abraha A., Lagalwar S., Guillozet A.L., et al. Caspase cleavage of tau: linking amyloid and neurofibrillary tangles in Alzheimer's disease. Proc Natl Acad Sci USA 100 (2003) 10032-10037
67. Yoneda S., Hara H., Hirata A., Fukushima M., Inomata Y., and Tanihara H. Vitreous fluid levels of beta-amyloid (1-42) and tau in patients with retinal diseases. Jpn J Ophthalmol 49 (2005) 106-108
68. Engelborghs S, De Vreese K, Van de Casteele T, Vanderstichele H, Van Everbroeck B, Cras P, Martin JJ, Vanmechelen E, De Deyn PP. Diagnostic performance of a CSF-biomarker panel in autopsy-confirmed dementia. Neurobiol Aging 2007, doi:10.1016/j.neurobiolaging.2007.02.016.
69. Tahzib N.G., Ransom N.L., Reitsamer H.A., and McKinnon S.J. Alpha-fodrin is cleaved by caspase-3 in a chronic ocular hypertensive (COH) rat model of glaucoma. Brain Res Bull 62 (2004) 491-495
70. Silverberg G.D., Mayo M., Saul T., Carvalho J., and McGuire D. Novel ventriculo-peritoneal shunt in Alzheimer's disease cerebrospinal fluid biomarkers. Expert Rev Neurother 4 (2004) 97-107
71. Bech R.A., Waldemar G., Gjerris F., Klinken L., and Juhler M. Shunting effects in patients with idiopathic normal pressure hydrocephalus; correlation with cerebral and leptomeningeal biopsy findings. Acta Neurochir (Wien) 141 (1999) 633-639
72. Savolainen S., Paljarvi L., and Vapalahti M. Prevalence of Alzheimer's disease in patients investigated for presumed normal pressure hydrocephalus: a clinical and neuropathological study. Acta Neurochir (Wien) 141 (1999) 849-853
73. Golomb J., Wisoff J., Miller D.C., Boksay I., Kluger A., Weiner H., et al. Alzheimer's disease comorbidity in normal pressure hydrocephalus: prevalence and shunt response. J Neurol Neurosurg Psychiatry 68 (2000) 778-781
74. Silverberg G.D., Huhn S., Jaffe R.A., Chang S.D., Saul T., Heit G., et al. Downregulation of cerebrospinal fluid production in patients with chronic hydrocephalus. J Neurosurg 97 (2002) 1271-1275
75. Silverberg G.D., Levinthal E., Sullivan E.V., Bloch D.A., Chang S.D., Leverenz J., et al. Assessment of low-flow CSF drainage as a treatment for AD: results of a randomized pilot study. Neurology 59 (2002) 1139-1145
76. Kapaki E.N., Paraskevas G.P., Tzerakis N.G., Sfagos C., Seretis A., Kararizou E., et al. Cerebrospinal fluid tau, phospho-tau 181 and beta-amyloid 1-42 in idiopathic normal pressure hydrocephalus: a discrimination from Alzheimer's disease. Eur J Neurol 14 (2007) 168-173
77. Czosnyka M., Czosnyka Z., Schmidt E.A., and Momjian S. Cerebrospinal fluid production. J Neurosurg 99 (2003) 206-207 [author reply 207]
78. Hochwald G.M., Sahar A., Sadik A.R., and Ransohoff J. Cerebrospinal fluid production and histological observations in animals with experimental obstructive hydrocephalus. Exp Neurol 25 (1969) 190-199
79. Johnson R.T., and Johnson K.P. Hydrocephalus following viral infection: the pathology of aqueductal stenosis developing after experimental mumps virus infection. J Neuropathol Exp Neurol 27 (1968) 591-606
80. Silverberg G.D., Heit G., Huhn S., Jaffe R.A., Chang S.D., Bronte-Stewart H., et al. The cerebrospinal fluid production rate is reduced in dementia of the Alzheimer's type. Neurology 57 (2001) 1763-1766
81. May C., Kaye J.A., Atack J.R., Schapiro M.B., Friedland R.P., and Rapoport S.I. Cerebrospinal fluid production is reduced in healthy aging. Neurology 40 (1990) 500-503
82. Serot J.M., Bene M.C., Foliguet B., and Faure G.C. Morphological alterations of the choroid plexus in late-onset Alzheimer's disease. Acta Neuropathol (Berl) 99 (2000) 105-108
83. Serot J.M., Bene M.C., and Faure G.C. Choroid plexus, aging of the brain, and Alzheimer's disease. Front Biosci 8 (2003) s515-s521
84. Knuckey N.W., Preston J., Palm D., Epstein M.H., and Johanson C. Hydrocephalus decreases chloride efflux from the choroid plexus epithelium. Brain Res 618 (1993) 313-317
85. Johanson C., McMillan P., Tavares R., Spangenberger A., Duncan J., Silverberg G., et al. Homeostatic capabilities of the choroid plexus epithelium in Alzheimer's disease. Cerebrospinal Fluid Res 1 (2004) 3
86. Jiang G., Akar F., Cobbs S.L., Lomashvilli K., Lakkis R., Gordon F.J., et al. Blood pressure regulates the activity and function of the Na-K-2Cl cotransporter in vascular smooth muscle. Am J Physiol Heart Circ Physiol 286 (2004) H1552-H1557
87. Johanson C.E., Jones H.C., Stopa E.G., Ayala C., Duncan J.A., and McMillan P.N. Enhanced expression of the Na-K-2Cl cotransporter at different regions of the blood-CSF barrier in the perinatal H-Tx rat. Eur J Pediatr Surg 12 Suppl. 1 (2002) S47-S49
88. Wessel K., Thron A., Linden D., Petersen D., and Dichgans J. Pseudotumor cerebri: clinical and neuroradiological findings. Eur Arch Psychiatry Neurol Sci 237 (1987) 54-60
89. Higgins J.N., Cousins C., Owler B.K., Sarkies N., and Pickard J.D. Idiopathic intracranial hypertension: 12 cases treated by venous sinus stenting. J Neurol Neurosurg Psychiatry 74 (2003) 1662-1666
90. Bateman G.A. Pulse wave encephalopathy: a spectrum hypothesis incorporating Alzheimer's disease, vascular dementia and normal pressure hydrocephalus. Med Hypotheses 62 (2004) 182-187
91. Peng J.H., Kung F.T., Peng W., and Parker Jr. J.C. Increased ALZ-50 immunoreactivity in CSF of pseudotumor cerebri patients. Ann Clin Lab Sci 36 (2006) 151-156
92. Levine D.N. Ventricular size in pseudotumor cerebri and the theory of impaired CSF absorption. J Neurol Sci 177 (2000) 85-94